Pharmacists are well-positioned to deliver what’s needed to meet the clinical and economic burdens of community healthcare, particularly when it comes to diabetes care.
Leana Salamah, vice president of marketing at the International Housewares Association, discusses how drug stores have always been a purveyor of curative wellness for consumers.
Charisse Jacques, GM and chief customer centric retailing officer at SymphonyAI Retail CPG, looks at how drug stores need to make the most out of existing loyalty data.
Vish Kulkarni of Rockley Photonics explains how wearable devices could play a larger role in preventing viruses, such as COVID-19 from growing to severe status unnoticed.
Nihal Advani, founder and CEO of QualSights, takes a look at how QR codes can be an efficient method of gathering customer satisfaction data for retailers and retail pharmacies.
NACDS president and CEO Steve Anderson is calling on Congress to prioritize consumer health and safety, and to help stamp out organized retail crime before year’s end.
The approval means that pharmacists will be allowed to switch out Lantus (insulin glargine) for the Semglee (insulin glargine-yfgn) biosimilar without the required approval from the prescribing physician.
The program can provide access to lifesaving treatments, and allowing pharmacists to prescribe and dispense will make it more effective and accessible for millions of Americans.
Roche Diabetes Care’s senior vice president and general manager lists ways the company works with pharmacies to support diabetes patients when and where they need it.
The COVID-19 pandemic has altered the CPG retail landscape, driving unprecedented growth and transforming the industry as we know it. New product innovation has leveraged many existing trends, including self-care.
Peter Koo, Mckesson vice president and general manager of pharmacy solutions, offers two considerations for building a brighter future for retail pharmacy.
LogiNext CEO Dhruvil Sanghvi discusses the growing importance of flexible prescription fulfillment among patients, and how the last mile is increasingly the most important element of fulfillment.
LexisNexis Risk Solutions’ Craig Ford outlines some of the ways pharmacies can use data on social determinants of health to inform their clinical offerings and improve patient health.
Jeffrey K. France, vice president and general counsel at the Association for Accessible Medicines, discusses how two major decisions made by the Supreme Court implicates the biopharmaceutical competition.
Mack Elevation’s Dan Mack shares insights from suppliers and retailers about how both are approaching their business relationships and offers advice for strengthening the supplier-retailer partnership.
AmerisourceBergen's George Rafferty discusses the role that strategic partnerships play in pharmacies' ability to respond to their patients’ needs — throughout the pandemic and beyond.
McKesson Pharmacy Systems’ Heather Cusick writes about the opportunity that COVID-19 vaccination efforts present for pharmacies to improve their vaccine workflow and further demonstrate value to patients.
Alan Van Amber and Julie Olson of Navitus Health Solutions discuss how pharmacists can work with patients to improve their adherence and, ultimately, their quality of life.
ECRM CEO Greg Farrar discusses the ECRM Connect platform and how it has enabled continued product discovery and collaboration between companies throughout the pandemic.
Marketing Werks’ Ellie Meyer discusses the ways that retailers can provide in-store, online and experiential offerings to build shoppers’ trust in them.
FDS chief clinical officer Jason Ausili offers tips for best practices in administering COVID-19 and highlights opportunities the moment presents for pharmacies.
Christine Burdick-Bell, steering committee chair at the Dietary Supplements Quality Collaborative, outlines where dietary supplement regulations stand as the Biden administration gets settled.
Jonathan Ni and Nicholas Benedict discuss how some observers have questioned whether physician dispensing programs are contributing to this opioid crisis.
ScriptDrop’s Amanda Epp discusses how despite pharmacists’ importance in the healthcare system, there still is an opportunity for them to take on a larger role.
McKesson’s Mike Cihlar outlines the ways that pharmacy’s strengths have shown throughout the pandemic and what it means for the future of the industry.